# Jan Östergren

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jan-ostergren/

## Facts

| Field | Value |
| --- | --- |
| Citations | 33,124 |
| Field | Heart Failure Treatment and Management |
| h-index | 54 |
| i10-index | 119 |
| Last Known Institution | Karolinska Institutet |
| OpenAlex ID | https://openalex.org/A5028660133 |
| ORCID iD | https://orcid.org/0000-0001-5676-3195 |
| Works | 204 |

## Researcher papers

- [Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial](https://scholariq.org/papers/prevention-of-coronary-and-stroke-events-with-atorvastatin-in-hypertensive/)
- [Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial](https://scholariq.org/papers/effects-of-candesartan-in-patients-with-chronic-heart-failure-and-preserved-left/)
- [Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial](https://scholariq.org/papers/prevention-of-cardiovascular-events-with-an-antihypertensive-regimen-of/)
- [Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial](https://scholariq.org/papers/effects-of-candesartan-in-patients-with-chronic-heart-failure-and-reduced-left/)
- [ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD](https://scholariq.org/papers/esc-guidelines-on-diabetes-pre-diabetes-and-cardiovascular-diseases-developed-in/)
- [Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme](https://scholariq.org/papers/effects-of-candesartan-on-mortality-and-morbidity-in-patients-with-chronic-heart/)
- [Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)](https://scholariq.org/papers/guidelines-on-diabetes-pre-diabetes-and-cardiovascular-diseases-executive/)
- [ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries * The Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC)](https://scholariq.org/papers/esc-guidelines-on-the-diagnosis-and-treatment-of-peripheral-artery-diseases/)
- [Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure](https://scholariq.org/papers/renal-function-as-a-predictor-of-outcome-in-a-broad-spectrum-of-patients-with/)
- [Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: An analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme](https://scholariq.org/papers/impact-of-diabetes-on-outcomes-in-patients-with-low-and-preserved-ejection/)
- [Sex Differences in Clinical Characteristics and Prognosis in a Broad Spectrum of Patients With Heart Failure](https://scholariq.org/papers/sex-differences-in-clinical-characteristics-and-prognosis-in-a-broad-spectrum-of/)
- [Clinical Correlates and Consequences of Anemia in a Broad Spectrum of Patients With Heart Failure](https://scholariq.org/papers/clinical-correlates-and-consequences-of-anemia-in-a-broad-spectrum-of-patients/)

## Researcher topics

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Peripheral Artery Disease Management](https://scholariq.org/topics/peripheral-artery-disease-management/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Researcher university

- [Karolinska Institutet](https://scholariq.org/institutions/karolinska-institutet/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.